GFAP and age-related macular degeneration: GFAP protein expression increased at an earlier phase following AMD3100 treatment (Figure 6(c), P < 0.05, Dia vs. AMD), but no remarkable changes were seen at the later phase (Figures 6(f)–6h, P > 0.05, Dia vs. AMD).